Oramed Pharmaceuticals (ORMP) Receivables - Net (2011 - 2018)

Oramed Pharmaceuticals has reported Receivables - Net for 8 years, with the latest figure at $65000.0 in Q1 2018.

• For the quarter ending Q1 2018, Receivables - Net changed N/A year-over-year to $65000.0; the trailing twelve-month figure through Feb 2018 stood at $65000.0 (changed N/A YoY), and the FY2017 full-year result was $65000.0, changed 0.0% from the prior year.
• Receivables - Net for Q1 2018 stood at $65000.0, roughly flat from $65000.0 in the prior quarter.
• The five-year high for Receivables - Net was $2.2 million in Q2 2015, with the low at $65000.0 in Q3 2014.
• Historically, Receivables - Net has averaged $204673.7 across 5 years, with a median of $65000.0 in 2014.
• Annual changes were most pronounced in 2015 — Receivables - Net jumped 3220.37% — and 2016, when it plunged 96.99%.
• Oramed Pharmaceuticals' Receivables - Net stood at $65000.0 in 2014, then changed by 0.0% to $65000.0 in 2015, then changed by 0.0% to $65000.0 in 2016, then changed by 0.0% to $65000.0 in 2017, then changed by 0.0% to $65000.0 in 2018.
• The last three Receivables - Net figures came in at $65000.0 (Q1 2018), $65000.0 (Q4 2017), and $65000.0 (Q3 2017), per Business Quant data.